Search research articles
Contact Us
Filters
Showing results (11-20 of 220) with videos related to
Page
of 22
Sort By:
Expert Review of Anti-Infective Therapy
|
September 29, 2015
Future treatment options for human African trypanosomiasis
Amy J Jones, Vicky M Avery
Journal of Natural Products
|
February 25, 2009
Leptoclinidamines A-C, indole alkaloids from the Australian ascidian Leptoclinides durus
Anthony R Carroll, Vicky M Avery
International Journal for Parasitology. Drugs and Drug Resistance
|
April 28, 2016
Development and application of a sensitive, phenotypic, high-throughput image-based assay to identify compound activity against Trypanosoma cruzi amastigotes
Melissa L Sykes, Vicky M Avery
Expert Opinion on Drug Discovery
|
April 2, 2013
Whole-organism high-throughput screening against Trypanosoma brucei brucei
Amy J Jones, Vicky M Avery
The American Journal of Tropical Medicine and Hygiene
|
October 10, 2009
Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427
Melissa L Sykes, Vicky M Avery
Parasites & Vectors
|
November 14, 2009
A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427
Melissa L Sykes, Vicky M Avery
Journal of Medicinal Chemistry
|
August 10, 2013
Approaches to protozoan drug discovery: phenotypic screening
Melissa L Sykes, Vicky M Avery
Drug Discovery Today
|
December 5, 2020
Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy
Elke Kaemmerer, Daniela Loessner, Vicky M Avery
Scientific Reports
|
April 6, 2017
The need to compare: assessing the level of agreement of three high-throughput assays against Plasmodium falciparum mature gametocytes
Leonardo Lucantoni, Sasdekumar Loganathan, Vicky M Avery
Antimicrobial Agents and Chemotherapy
|
September 12, 2024
An adaptable, fit-for-purpose screening approach with high-throughput capability to determine speed of action and stage specificity of anti-malarial compounds
Sandra Duffy, Brad E Sleebs, Vicky M Avery
Page
of 22
Search research articles
Search
Showing results (11-20 of 220) with videos related to
Sort By:
Page
of 22
Expert Review of Anti-Infective Therapy
|
September 29, 2015
Future treatment options for human African trypanosomiasis
Amy J Jones, Vicky M Avery
Journal of Natural Products
|
February 25, 2009
Leptoclinidamines A-C, indole alkaloids from the Australian ascidian Leptoclinides durus
Anthony R Carroll, Vicky M Avery
International Journal for Parasitology. Drugs and Drug Resistance
|
April 28, 2016
Development and application of a sensitive, phenotypic, high-throughput image-based assay to identify compound activity against Trypanosoma cruzi amastigotes
Melissa L Sykes, Vicky M Avery
Expert Opinion on Drug Discovery
|
April 2, 2013
Whole-organism high-throughput screening against Trypanosoma brucei brucei
Amy J Jones, Vicky M Avery
The American Journal of Tropical Medicine and Hygiene
|
October 10, 2009
Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427
Melissa L Sykes, Vicky M Avery
Parasites & Vectors
|
November 14, 2009
A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427
Melissa L Sykes, Vicky M Avery
Journal of Medicinal Chemistry
|
August 10, 2013
Approaches to protozoan drug discovery: phenotypic screening
Melissa L Sykes, Vicky M Avery
Drug Discovery Today
|
December 5, 2020
Addressing the tumour microenvironment in early drug discovery: a strategy to overcome drug resistance and identify novel targets for cancer therapy
Elke Kaemmerer, Daniela Loessner, Vicky M Avery
Scientific Reports
|
April 6, 2017
The need to compare: assessing the level of agreement of three high-throughput assays against Plasmodium falciparum mature gametocytes
Leonardo Lucantoni, Sasdekumar Loganathan, Vicky M Avery
Antimicrobial Agents and Chemotherapy
|
September 12, 2024
An adaptable, fit-for-purpose screening approach with high-throughput capability to determine speed of action and stage specificity of anti-malarial compounds
Sandra Duffy, Brad E Sleebs, Vicky M Avery
Page
of 22